The Journal is included in Russian and International Library and Abstract Databases
Russain Science Index (Russia)
EBSCO
DOI Registration Agency (USA)
Scientific Indexing Services (USA)
CAS Source index (USA)
Web of Science Group (USA)

Development of the Russian pharmaceutical market: index analysis

DOI: https://doi.org/10.29296/25419218-2019-06-01
Issue: 
6
Year: 
2019

E.O. Trofimova(1), M.N. Denisova(2), A.S. Orlov(1) 1-Saint Petersburg State Chemopharmaceutical University, 14A, Prof. Popov St., Saint Petersburg 197376, Russian Federation; 2-I.M. Sechenov First Moscow State Medical University (Sechenov University), 8, Trubetskaya St., Build. 2, Moscow 119048, Russian Federation

Introduction. In 2017, the Russian pharmaceutical market showed an increase in both wholesale prices and volume terms. However, long-term trends indicate a slowdown in the dynamics of its development. The main growth of the Russian pharmaceutical market in 2017 was achieved through public procurements, rather than pharmacy sales to the population, as was typical of previous years. Different government regulatory instruments are gaining more and more influence on the pharmaceutical market Objective: to analyze development trends of the main segments of the Russian pharmaceutical market in 2017. Material and methods. The study was conducted using the IQVIA drug sales data. A system of interrelated indices (price index, structural change index, weighted average price index, sales volume change index) was used. The indices were calculated for the segment of pharmacy sales to the population, as well as for individual segments of the government procurement market. Results. Various factors were determined to contribute to the growth of individual market segments in value terms in 2017. There was a general tendency to lower prices and positive structural changes in the segments of the public procurement market. Total purchase volumes rose in proportion to the growth of financing. The weighted average prices basically either unchanged or decreased, which can be considered as evidence for the enhanced efficiency of using the public funds. The pharmacy market segment exhibited a slight positive price changes with reduced sales volumes. The main factor ensuring an increase in retail sales in value terms in 2017 was a change in the structure of demand in favor of more expensive products. There was evidence that there was a relationship between price changes and the degree of centralization of purchasing. Conclusion. A tendency to lower prices in the main segments of the government medicine procurement market, a change in the market structure in favor of more expensive innovative drugs, and an increase in the volume of purchases are suggestive of the enhanced efficiency of using the public funds.

Keywords: 
pharmaceutical market
pharmacy sales
public procurement segment
interrelated index system
weighted average prices

References: 
  1. Ishmuhametov A.A. (ed.) Russian Pharmaceutical Market: Results of 2017. Moscow: 2018 (in Russian).
  2. Ishmuhametov A.A. (ed.) Russian pharmaceutical market: Results of 2016. Moscow: 2017 (in Russian).
  3. Ishmuhametov A.A. (ed.) Russian pharmaceutical market: Results of 2015. Moscow: 2016 (in Russian).
  4. Oreshkin M.S. Prospects of economic policy. Ekonomicheskaya Politika. 2018; 13 (3): 8–27. DOI: 10.18288 / 1994-5124-2018-3-01 (in Russian).
  5. Orlov A.S. Analysis of the level and dynamics of drug prices. Modern methods. New pharmacy. Effektivnoe upravlenie. 2015; 1: 16–25 (in Russian).
  6. Trofimova E.O. Price regulation and price level. Remedium. 2005; 5: 42–9 (in Russian).
  7. Kudrin A.L, Sokolov I.A. Fiscal policy as a source of economic growth. Voprosy ekonomiki. 2017; 9: 5–27 (in Russian).